21 July 2021 | News
GeneStore has been critical in bringing about a market correction in terms of affordability of COVID-19 RT-PCR kits manufacturing and testing to both the Indian and French markets
Genestore was recently awarded the 'Best Investment in France' laurel by the Business France department of the French Embassy in India at the Indo-France awards held in New Delhi. The announcement was made at an award ceremony in New Delhi in the presence of his excellency Emmanuel Lenain, the French ambassador to India and Eric Fajole, Trade Commissioner - Embassy of France.
The recognition boosts the scope of Indo-French business ties, wherein the Indian-origin diagnostics company, GeneStore has been critical in bringing about a market correction in terms of affordability of COVID-19 RT-PCR kits manufacturing and testing to both the Indian and French markets by undertaking a joint technology development and local manufacturing programme in both countries.
"This recognition heralds a new growth era in the Indian biotech sector where mid-sized Indian corporates are expanding globally and enhancing their access to technology and manufacturing know-how," added Anubhav Anusha, Global CEO, GeneStore.
GeneStore is now investing over 10 million euros (Rs 80 crores) over the next 18 months across enhancing research and manufacturing capabilities in France, India, Latin America, and Africa to work towards managing and eradicating infectious diseases globally. Furthermore, GeneStore is also investing in a biotech and healthcare technology incubator in India to provide Indian research talent with the framework to develop strong business models and access the global market.